1 Min Read
Oct 14 (Reuters) - Provectus Biopharmaceuticals Inc
* Trading in Provectus Biopharmaceuticals common stock and warrants suspended by NYSE market
* Provectus plans to appeal decision of NYSE market Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.